Clinical trial
Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH…
NCT00421148 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00421148 |
|---|---|
| Title | Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961) |
| Official title | A Multi-Center, Randomized, Parallel Dose-Finding, Safety Assessor-Blinded Trial to Explore the Efficacy, Safety and Pharmacokinetics of Four Doses of Org 25969 and Placebo in Pediatric and Adult Subjects. |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia |
| Intervention type | Drug |
| Interventions | Sugammadex 0.5 mg/kg, Sugammadex 1 mg/kg, Sugammadex 2 mg/kg, Sugammadex 4 mg/kg, Placebo, Rocuronium bromide |
| Enrollment | 94 |
| Start date | May 30, 2005 |
| Primary completion | May 31, 2006 |
| Completion | Jun 2, 2006 |
| First posted | Jan 11, 2007 |
| Last update posted | Jan 28, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: